| Intercell, Merck S. Aureus Shot Effective in Renal Disease - Bloomberg |
|
|
Bloomberg s experimental vaccine against a deadly hospital infection provoked an immune response in a trial of patients with end- stage renal disease. The study, from the second of three phases of human testing generally required for regulatory approval, |